Notes / Company

Biocon Ltd.

BIOCON BSE 532523 ISIN INE376G01013 Pharmaceuticals

Fundamentals

Market cap: ₹67,454 cr
P/E: 174.93×
ROE: 4.68%
Debt / equity: 0.82
Div yield: 0.12%
52-week range: 331.00 — 440.40

Research on Tijori Finance

Company snapshot

Biocon Ltd.

Pharmaceuticals

₹68,354 cr

P/E 177.27×

Latest quarter · Mar 2026

Sales₹4,517 cr

Net profit₹199 cr

Op. margin+22.6%

EPS₹0.78

Strength & growth

Debt / equity0.82×

Current ratio1.14×

Sales CAGR+17.6%

EPS CAGR−6.2%

The timeline — 1 note on Biocon Ltd.

June 2026

24 Jun 26 · 8:37 AM IST Brief

Brief · Large cap

Biocon scores MYR 225 mn insulin supply deal in Malaysia

Duopharma Biotech's tender wins from Malaysia's MOH secure Biocon a three-drug supply agreement, but the annualized revenue is modest relative to its size.

Verify on exchange BSE filings for BIOCON NSE filings for BIOCON Tijori Finance company page